Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-01-07 @ 12:12 AM
Study NCT ID:
NCT05028634
Status:
COMPLETED
Last Update Posted:
2025-02-11
First Post:
2021-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy
Sponsor:
Celgene
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RPC-1063-MS-010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None